DIABETES Cardiovascular benefits of metformin in T1DM

被引:4
作者
Snell-Bergeon, Janet K. [1 ]
机构
[1] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Barbara Davis Ctr, Anschutz Med Campus,POB F527, Aurora, CO 80045 USA
关键词
INSULIN-RESISTANCE; TYPE-1;
D O I
10.1038/nrendo.2017.116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Results from the Reducing with Metformin Vascular Adverse Lesions (REMOVAL) study show for the first time that metformin has a cardiovascular benefit in patients with type 1 diabetes mellitus (T1DM), although the benefit was limited to tertiary outcomes and was modest. Additional measures are therefore needed to reduce cardiovascular disease in patients with T1DM.
引用
收藏
页码:565 / +
页数:2
相关论文
共 50 条
[31]   Cardiovascular Function/Dysfunction in Adolescents with Type 1 Diabetes [J].
Kristen J. Nadeau ;
Jane E. B. Reusch .
Current Diabetes Reports, 2011, 11 :185-192
[32]   Type 1 diabetes, metabolic syndrome and cardiovascular risk [J].
Chillaron, Juan J. ;
Flores Le-Roux, Juana A. ;
Benaiges, David ;
Pedro-Botet, Juan .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (02) :181-187
[33]   Cardiovascular Function/Dysfunction in Adolescents with Type 1 Diabetes [J].
Nadeau, Kristen J. ;
Reusch, Jane E. B. .
CURRENT DIABETES REPORTS, 2011, 11 (03) :185-192
[34]   Variants within the calpain-10 gene and relationships with type 2 diabetes (T2DM) and T2DM-related traits among Tunisian Arabs [J].
Ezzidi, I. ;
Mtiraoui, N. ;
Nemr, R. ;
Kacem, M. ;
Al-Khateeb, G. M. ;
Mahjoub, T. ;
Almawi, W. Y. .
DIABETES & METABOLISM, 2010, 36 (05) :357-362
[35]   Cardiovascular endocrinology 1 - Aldosterone function in diabetes mellitus: Effects on cardiovascular and renal disease [J].
McFarlane, SI ;
Sowers, JR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) :516-523
[36]   The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review* [J].
Wang, Mengjiao ;
Chen, Min ;
Guo, Rui ;
Ding, Yangyang ;
Zhang, Haihui ;
He, Yuanqing .
TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2022, 129 :397-407
[37]   The Anti-Diabetic, Lipidemic, And Pro-Inflammatory Effects of Metformin Versus Glibenclamide on T2DM Obese Patients [J].
Hamdy, Naglaa ;
Abdel-Gabbar, Mohamed ;
Sakr, Hader I. ;
Gaber, Safy S. ;
Kandeil, Mohamed ;
Aziz, Ayman M. Abdel ;
Ahmed, Osama M. .
EGYPTIAN JOURNAL OF CHEMISTRY, 2025, 68 (04) :91-101
[38]   Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM) [J].
Souto, Selma B. ;
Souto, Eliana B. ;
Braga, Daniel C. ;
Medina, Jose L. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (07) :653-661
[39]   Type 2 Diabetes (T2DM) and Parkinson's Disease (PD): a Mechanistic Approach [J].
Sabari, S. Sri ;
Balasubramani, Kiruthika ;
Iyer, Mahalaxmi ;
Sureshbabu, Harysh Winster ;
Venkatesan, Dhivya ;
Gopalakrishnan, Abilash Valsala ;
Narayanaswamy, Arul ;
Senthil Kumar, Nachimuthu ;
Vellingiri, Balachandar .
MOLECULAR NEUROBIOLOGY, 2023, 60 (08) :4547-4573
[40]   Association of Abdominal Obesity with Atherosclerosis in Type 2 Diabetes Mellitus (T2DM) in Korea [J].
Cho, Minho ;
Park, Jong Suk ;
Nam, Jisun ;
Kim, Chul Sik ;
Nam, Jae Hyun ;
Kim, Hai Jin ;
Ahn, Chul Woo ;
Cha, Bong Soo ;
Lim, Sung Kil ;
Kim, Kyung Rae ;
Lee, Hyun Chul ;
Huh, Kap Bum .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (05) :781-788